The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta‐Analysis

@article{Golikhatir2019TheEA,  title={The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta‐Analysis},  author={Iraj Golikhatir and Hamed Cheraghmakani and Farzad Bozorgi and Fatemeh Jahanian and Mohammad Sazgar and Seyed Hossein Montazer},  journal={Headache: The Journal of Head and Face Pain},  year={2019},  volume={59},  url={https://api.semanticscholar.org/CorpusID:119544256}}
The aim of this review was to evaluate the efficacy and safety of prochlorperazine (PCP) in patients with acute migraine headache in the emergency department (ED).

27 Citations

The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis

To assess the comparative effectiveness and safety of parenteral agents for pain reduction in patients with acute migraine.

Prochlorperazine for treatment of acute migraines in adults.

Migraine headache results in over 1 million emergency department visits per year in the United States.1-3 Several treatments have been offered to treat the headache.4-6 Prochlorperazine has been

The efficacy of dexketoprofen for migraine attack

Abstract Background: The efficacy of dexketoprofen for migraine attack remains controversial. We conduct a systematic review and meta-analysis to explore the influence of dexketoprofen

TO DETERMINE THE EFFICACY OF KETOROLAC IN DECREASING THE SEVERITY OF HEADACHE

Korolac appears to be a safe and well-tolerated means of controlling pain in patients with primary headache in emergency departments, and has a pronounced effect that is even more pronounced within 1 hour after application and 2 hours later.

THE EFFECTIVENESS OF KETOROLAC AS AN ANALGESIC FOR CONTROLLING PRIMARY HEADACHE IN EMERGENCY DEPARTMENT OF JINNAH HOSPITAL

Korolac appears to be a safe and well-tolerated means of controlling pain in patients with primary headache in emergency departments, and has a pronounced effect that is even more pronounced within 1 hour after application and 2 hours later.

THE EFFECTIVENESS OF KETOROLAC AS AN ANALGESIC FOR CONTROLLING PRIMARY HEADACHE IN EMERGENCY DEPARTMENTS

Korolac appears to be a safe and well-tolerated means of controlling pain in patients with primary headache in emergency departments, and has a pronounced effect that is even more pronounced within 1 hour after application and 2 hours later.

Best Practices, Resources and Innovations: A Mechanistic Review of Nausea and Vomiting Management Options in Cirrhosis

A mechanistic review of available anti-emetic medications along with practical strategies of use and future areas of study in patients with cirrhosis is aimed at providing a safe and educated treatment of nausea and vomiting.

Intranasal lidocaine for acute migraine: A meta-analysis of randomized controlled trials

Intranasal lidocaine can be considered a useful option for patients with an acute migraine because it yields a high success rate, a low pain intensity, an infrequent need for rescue medicine, and tolerable adverse events.

Comparison of the efficacy of intranasal ketamine versus intravenous ketorolac on acute non-traumatic headaches: a randomized double-blind clinical trial

Intranasal ketamine and intravenous ketorolac both effectively reduced headaches, however, more analgesic effects of intranasAL ketamine in a short time can be considered as a selective approach to reducing headaches.

41 References

Efficacy and Tolerability of Prochlorperazine Buccal Tablets in Treatment of Acute Migraine

This study aims to study the efficacy and tolerability of prochlorperazine (PCZ) management of acute migraine in patients with acute migraine.

Migraine Treatment in the Emergency Department: Alternatives to Opioids and their Effectiveness in Relieving Migraines and Reducing Treatment Times

Dopamine receptor antagonists, such as metoclopramide and prochlorperazine, were the most efficacious in terminating migraines in the studies examined.

Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies

This work addressed two clinically relevant questions: which injectable medications should be considered first‐line treatment for adults who present to an ED with acute migraine and do parenteral corticosteroids prevent recurrence of migraine in adults discharged from an ED.

Rescue Therapy for Acute Migraine, Part 3: Opioids, NSAIDs, Steroids, and Post‐Discharge Medications

Objective.— The final section of this 3‐part review analyzes published reports involving the acute treatment of migraine with opioids, non‐steroidal anti‐inflammatory drugs (NSAIDs), and steroids in

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences

To evaluate gender differences in sociodemographics and headache features; consultation and diagnosis patterns; and patterns of acute and preventive treatment use for migraine among study participants, baseline methods for the MAST Study are summarized.

A Retrospective Nested Cohort Study of Emergency Department Revisits for Migraine in New York City

The goal of this analysis was to determine the frequency of headache revisits among patients who present to an ED for management of migraine and sociodemographic factors associated with the revisit.

Related Papers

Showing 1 through 3 of 0 Related Papers